Mark J. Vignola is CFO at Terns Pharmaceuticals, Inc. (TERN). They have made 5 open-market trades across 1 company since 2022, most recently 2025-01-06.
CIK 0001775429
5 open-market purchases totalling $49K since 2022, never a sale. Across 5 scored buys the stock is up 22.8% at ninety days, and 19.6 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| TERN | 83,811 | $4.4M |
Shares reported on the most recent Form 4, priced at the 2025-01-06 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 60% | 80% | 80% |
| Avg Move | +9.9% | +6.3% | +22.8% |
| Alpha | +9.7% | +5.4% | +19.6% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | SELL · 10b5-1 | 2025-01-02 | 2025-01-06 | $5.78 | $152K | -22.4% | -18.4% | -65.0% |
| TERN | SELL · 10b5-1 | 2024-09-10 | 2024-09-12 | $11.00 | $110K | +2.8% | -18.5% | -28.3% |
| TERN | BUY | 2024-05-31 | 2024-06-04 | $4.44 | $21K | +36.7% | +13.5% | +20.5% |
| TERN | BUY | 2023-11-30 | 2023-12-04 | $3.78 | $3K | +6.9% | +3.8% | +22.8% |
| TERN | BUY | 2023-05-31 | 2023-06-02 | $1.41 | $14K | -0.7% | -30.2% | -55.5% |
| TERN | BUY | 2022-11-30 | 2023-02-03 | $1.41 | $4 | +9.9% | +12.2% | +34.2% |
| TERN | BUY | 2022-05-31 | 2022-06-08 | $1.47 | $11K | -3.5% | +32.3% | +92.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.